People who have been treated for multiple myeloma, including those who have undergone a stem cell transplant (SCT), have an increased risk of developing secondary cancers. These secondary cancers can develop years after the initial treatment and are often a long-term side effect of the cancer treatment itself. Common types Show Full Answer

People who have been treated for multiple myeloma, including those who have undergone a stem cell transplant (SCT), have an increased risk of developing secondary cancers. These secondary cancers can develop years after the initial treatment and are often a long-term side effect of the cancer treatment itself. Common types of secondary cancers include:

- Acute Myeloid Leukemia (AML): A fast-growing cancer that forms from white blood cells.
- Myelodysplastic Syndrome (MDS): A slower-growing disease that forms in blood cells of the bone marrow and can sometimes progress to AML.

Given your history of SCT in 2015, your hematologist's recommendation for a bone marrow biopsy is likely a precautionary measure to monitor for these potential secondary cancers. It's important to follow their advice and discuss any concerns you have with them.

 This AI-generated response comes from MyMyelomaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Second Cancers and Myeloma: Understanding the Connection | MyMyelomaTeam

Stem Cell Transplants for Multiple Myeloma: Your Guide | MyMyelomaTeam